Latest Pfizer Inc News
Taking a daily multivitamin appears to boost brains of adults over 60, but more study is needed
Millions of American adults take daily multivitamins, even though the pills have not been shown to prevent ailments like heart disease or cancer and experts say it’s better to get nutrients from food. The latest research looks at whether taking a daily vitamin can have an effect on...
NOT REAL NEWS: A look at what didn't happen this week
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ Claims misconstrue...
COVID-19 vaccine maker Novavax to chop workforce, expenses
Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general...
Over-the-counter birth control pill faces FDA questions
WASHINGTON (AP) — U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription. But in an initial review posted Friday, the Food and Drug Administration raised numerous concerns about drugmaker Perrigo’s application to...
Moderna tops 1Q forecasts; vaccine sales plunge as expected
Sales of Moderna’s COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall Street expected this and the drugmaker topped expectations. Moderna said Thursday that revenue from its Spikevax vaccine tumbled to $1.83 billion in the quarter from nearly $6...
Pfizer tops Q1 forecasts; vaccine sales slide as expected
Pfizer beat first-quarter forecasts as revenue took an expected dip, but the drugmaker predicted a sales rally later this year. The pharmaceutical giant said Tuesday that total revenue dropped 29% in quarter, as sales tumbled for its market-leading COVID-19 vaccine, Comirnaty. The...
Pfizer: Q1 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Tuesday reported first-quarter profit of $5.54 billion. The New York-based company said it had profit of 97 cents per share. Earnings, adjusted for non-recurring costs, were $1.23 per share. The results surpassed...
Merck has strong quarter even as COVID-19 treatment tumble
Merck beat first-quarter expectations and hiked its 2023 forecast even as sales plunged for its COVID-19 treatment and a strong dollar hurt revenue. Soaring sales of the drugmaker’s top seller, the cancer treatment Keytruda, helped counter those hits, a drop expected by analysts....
Senators press Moderna CEO on COVID-19 vaccine price hike
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health, Education,...
Editorial Roundup: United States
Excerpts from recent editorials in the United States and abroad: March 15 The Washington Post on voter fraud: A 59-year-old man was arrested last week for allegedly double voting in the 2020 presidential election. Florida authorities brought the felony...
